Metastatic Solid Cancer Clinical Trial

Clinical trial NCT04739618 · UNKNOWN

Trial details

NCT number: NCT04739618
Sponsor: ImmunSYS, LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer

Start date: 2021-03-04
Primary completion: 2024-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.